Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ASC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for Non-neridone intermediates via CN116082334A. High-yield resolution and scalable cyanation for cardiovascular API manufacturing.
Patent CN111377857B reveals a high-yield Milrinone synthesis route. Discover cost reduction in API manufacturing and supply chain reliability improvements.
Novel DMPU-free process for ASC21 synthesis reduces cost and pollution. Reliable pharmaceutical intermediate supplier offering scalable commercial production capabilities.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Patent CN102060778A details a high-yield 81% synthesis route for Olmesartan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1030583A reveals advanced synthesis of 6,7-diacyl-7-deacetylforskolin. Achieve superior selectivity and cost reduction in pharmaceutical intermediates manufacturing.
Novel cascade synthesis of all-carbon spiro compounds via Pd/Cu catalysis. Offers cost reduction in organic optoelectronic materials manufacturing with high purity and scalability.
Patent CN1175244A reveals a novel deprotection-isomerization route for high-purity agrochemical intermediates, offering significant cost reduction and scalable manufacturing solutions.
Novel copper-catalyzed air oxidation route for 3a,3a'-bipyrrole indolines. High yield, scalable process reduces cost and lead time for pharmaceutical manufacturing.
Patent CN116004562A reveals a quadruple transaminase mutant boosting D-4,4'-biphenylalanine production efficiency by 30-fold, offering a scalable, high-purity solution for LCZ696 intermediates.
Novel one-step base-catalyzed synthesis reduces heavy metal use and simplifies purification for pharmaceutical intermediates supply chains globally.
Patent CN118389613A reveals high-yield hydroxytyrosol synthesis. Offers cost reduction and supply chain reliability for food and pharma industries.
Novel process for NEP inhibitor intermediates offering scalable synthesis and significant cost reduction in pharmaceutical manufacturing ensuring supply chain reliability and high purity.
Patent CN1229366C reveals a superior 3-step route for Dronedarone intermediates, offering reduced waste and higher yields for reliable pharmaceutical supply chains.
Patent CN107365268A details advanced Fosinopril Sodium synthesis. Achieve high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Discover the advanced synthesis method for Mannityl Nicotinate achieving >99% purity. Learn about cost-effective production and reliable supply chain solutions.
Patent CN1622936A reveals a DCC-free route for perindopril synthesis, eliminating urea contaminants and ensuring high purity for reliable pharmaceutical intermediate supply chains.
Novel synthesis avoids toxic selenium dioxide and ketones. Improves solubility and activity significantly. Reliable supply for pharma intermediates ensuring cost reduction and continuity.
Patent CN101891677B reveals a green 2-step route to Mexidole using solid superacids. Achieve high purity and cost reduction in API manufacturing with scalable technology.
Patent CN102212572B details a yeast-displayed lipase method for L-ascorbyl oleate. Achieve higher purity and cost efficiency in antioxidant manufacturing with this novel biocatalytic route.